Chembio Enterprise Value vs Book Value per Share Analysis

CEMI
 Stock
  

USD 0.86  0.01  1.18%   

Chembio Diagnostics financial indicator trend analysis is way more than just evaluating Chembio Diagnostics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Chembio Diagnostics is a good investment. Please check the relationship between Chembio Diagnostics Enterprise Value and its Book Value per Share accounts. Continue to Trending Equities.

Enterprise Value vs Book Value per Share

Enterprise Value vs Book Value per Share Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Chembio Diagnostics Enterprise Value account and Book Value per Share. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Chembio Diagnostics' Enterprise Value and Book Value per Share is -0.22. Overlapping area represents the amount of variation of Enterprise Value that can explain the historical movement of Book Value per Share in the same time period over historical financial statements of Chembio Diagnostics, assuming nothing else is changed. The correlation between historical values of Chembio Diagnostics' Enterprise Value and Book Value per Share is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Enterprise Value of Chembio Diagnostics are associated (or correlated) with its Book Value per Share. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Book Value per Share has no effect on the direction of Enterprise Value i.e., Chembio Diagnostics' Enterprise Value and Book Value per Share go up and down completely randomly.

Correlation Coefficient

-0.22
Relationship DirectionNegative 
Relationship StrengthInsignificant

Enterprise Value

Enterprise Value (or EV) is usually referred to as Chembio Diagnostics theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Chembio Diagnostics debt, but would also pocket its cash. Enterprise Value is more accurate representation of Chembio Diagnostics value than its market capitalization because it takes into account all of Chembio Diagnostics existing debt. Enterprise value is a measure of the value of a business as a whole; calculated as Market Capitalization plus Total Debt USD minus Cash and Equivalents USD.

Book Value per Share

Measures the ratio between Shareholders Equity and [SharesWA] as adjusted by [ShareFactor].
Most indicators from Chembio Diagnostics fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Chembio Diagnostics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Continue to Trending Equities.Chembio Diagnostics Issuance Purchase of Equity Shares is most likely to increase significantly in the upcoming years. The last year's value of Issuance Purchase of Equity Shares was reported at 38.9 Million
 2019 2020 2021 2022 (projected)
Revenues USD34.46 M32.47 M47.82 M41.89 M
Revenues34.46 M32.47 M47.82 M41.89 M

Chembio Diagnostics fundamental ratios Correlations

0.610.950.970.960.860.960.930.860.920.83-0.710.870.660.980.960.940.90.930.950.630.69
0.610.780.590.770.290.660.490.790.460.7-0.850.710.020.520.570.770.390.80.531.00.28
0.950.780.910.980.710.960.870.940.850.94-0.860.850.430.90.920.990.80.990.90.790.61
0.970.590.910.940.90.940.930.820.930.79-0.650.890.660.980.950.910.940.90.950.60.62
0.960.770.980.940.740.990.890.940.880.89-0.840.880.490.910.940.980.840.980.920.780.62
0.860.290.710.90.740.770.90.590.910.59-0.350.710.780.910.880.720.940.70.90.30.51
0.960.660.960.940.990.770.920.910.910.87-0.790.860.540.920.950.950.880.950.940.670.65
0.930.490.870.930.890.90.920.841.00.77-0.660.690.580.910.990.880.980.860.990.50.6
0.860.790.940.820.940.590.910.840.830.87-0.960.720.240.780.880.930.760.940.850.80.63
0.920.460.850.930.880.910.911.00.830.76-0.640.680.60.910.990.860.990.850.990.470.6
0.830.70.940.790.890.590.870.770.870.76-0.830.710.230.780.840.950.70.950.810.70.54
-0.71-0.85-0.86-0.65-0.84-0.35-0.79-0.66-0.96-0.64-0.83-0.610.0-0.61-0.72-0.85-0.55-0.87-0.68-0.85-0.55
0.870.710.850.890.880.710.860.690.720.680.71-0.610.610.870.750.830.680.830.740.720.54
0.660.020.430.660.490.780.540.580.240.60.230.00.610.720.570.410.640.380.590.040.51
0.980.520.90.980.910.910.920.910.780.910.78-0.610.870.720.940.890.920.880.940.540.69
0.960.570.920.950.940.880.950.990.880.990.84-0.720.750.570.940.930.970.921.00.580.61
0.940.770.990.910.980.720.950.880.930.860.95-0.850.830.410.890.930.811.00.910.780.58
0.90.390.80.940.840.940.880.980.760.990.7-0.550.680.640.920.970.810.790.970.40.59
0.930.80.990.90.980.70.950.860.940.850.95-0.870.830.380.880.921.00.790.890.80.56
0.950.530.90.950.920.90.940.990.850.990.81-0.680.740.590.941.00.910.970.890.540.61
0.631.00.790.60.780.30.670.50.80.470.7-0.850.720.040.540.580.780.40.80.540.28
0.690.280.610.620.620.510.650.60.630.60.54-0.550.540.510.690.610.580.590.560.610.28
Click cells to compare fundamentals

Chembio Diagnostics Account Relationship Matchups

Chembio Diagnostics fundamental ratios Accounts

201720182019202020212022 (projected)
Inventories4.42 M7.85 M9.6 M12.52 M12.92 M13.94 M
Receivables2.09 M7.37 M3.66 M3.38 M11.44 M12.34 M
Accounts Payable1.49 M3.62 M3.14 M5.73 M7.75 M8.36 M
Total Assets16.62 M40.91 M55.73 M64.89 M73.25 M58.3 M
Current Assets10.85 M28.45 M32.22 M39.74 M55.23 M59.59 M
Assets Non Current5.76 M12.46 M23.51 M25.15 M18.02 M15.89 M
Cash and Equivalents3.79 M12.52 M18.27 M23.07 M28.77 M31.04 M
Cash and Equivalents USD3.79 M12.52 M18.27 M23.07 M28.77 M31.04 M
Deferred Revenue50 K422.9 K125 K1.61 M1.85 M1.99 M
Shareholders Equity13.08 M33.33 M24.04 M27.78 M34.26 M30.33 M
Shareholders Equity USD13.08 M33.33 M24.04 M27.78 M34.26 M30.33 M
Inventory4.42 M7.85 M9.6 M12.52 M12.92 M10.27 M
Total Liabilities3.54 M7.58 M31.69 M37.12 M38.99 M42.07 M
Current Liabilities3.1 M6.52 M6.44 M12.35 M15.28 M16.49 M
Trade and Non Trade Payables3.05 M5.89 M5.53 M10.04 M13.13 M14.16 M
Property Plant and Equipment Net1.91 M2.87 M13.17 M15.03 M14.64 M15.8 M
Trade and Non Trade Receivables2.09 M7.37 M3.66 M3.38 M11.44 M12.34 M
Accumulated Retained Earnings Deficit(50.04 M)(57.91 M)(71.59 M)(97.11 M)(131.01 M)(134.46 M)

Be your own money manager

Our tools can tell you how much better you can do entering a position in Chembio Diagnostics without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Aroon Oscillator Now

   

Aroon Oscillator

Analyze current equity momentum using Aroon Oscillator and other momentum ratios
All  Next Launch Module

Pair Trading with Chembio Diagnostics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chembio Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chembio Diagnostics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Chembio Diagnostics

0.71AXDXAccelerate Diagnosti Earnings Call  This WeekPairCorr

Moving against Chembio Diagnostics

0.51ABCAmerisourcebergen Corp Fiscal Year End 3rd of November 2022 PairCorr
The ability to find closely correlated positions to Chembio Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chembio Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chembio Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chembio Diagnostics to buy it.
The correlation of Chembio Diagnostics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chembio Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chembio Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chembio Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Trending Equities. Note that the Chembio Diagnostics information on this page should be used as a complementary analysis to other Chembio Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Complementary Tools for Chembio Stock analysis

When running Chembio Diagnostics price analysis, check to measure Chembio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chembio Diagnostics is operating at the current time. Most of Chembio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Chembio Diagnostics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chembio Diagnostics' price. Additionally, you may evaluate how the addition of Chembio Diagnostics to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Is Chembio Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chembio Diagnostics. If investors know Chembio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chembio Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
25.7 M
Quarterly Revenue Growth YOY
0.42
Return On Assets
-0.3
Return On Equity
-2.06
The market value of Chembio Diagnostics is measured differently than its book value, which is the value of Chembio that is recorded on the company's balance sheet. Investors also form their own opinion of Chembio Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Chembio Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chembio Diagnostics' market value can be influenced by many factors that don't directly affect Chembio Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chembio Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine Chembio Diagnostics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chembio Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.